Introduction
============

One of the extensively studied epigenetic effects of environmental chemicals is altered DNA methylation, a covalent modification of cytosine nucleotides in a CG dinucleotide context and an important mechanism of gene regulation. Toxicant effects on the DNA methylation process demonstrated so far include alterations in the expression of genes encoding DNA methyltransferases (DNMTs), the availability of DNA methylation substrates and the degree of CpG methylation in different regions of the genome. The majority of studies to date have focused on gene or locus-specific changes in DNA methylation. With the advent of high throughput bisulfite sequencing methods such as reduced representation bisulfite sequencing (RRBS) and whole genome bisulfite sequencing (WGBS), it has become possible to measure genome-wide changes in DNA methylation at base pair (bp) resolution \[[@dvy005-B1], [@dvy005-B2]\]. These methods have enabled identification of differentially methylated regions (DMRs) in diverse genomic locations including promoters, CpG islands, gene bodies and intergenic regions. As DNA methylation is one of the key mechanisms for regulating gene expression, concomitant analysis of the transcriptome and DNA methylome have been conducted to demonstrate the role of DNA methylation in transcriptional regulation. Recent studies have demonstrated very little correlation between these two processes \[[@dvy005-B3]\]. Similar studies investigating the impact of environmental chemicals on DNA methylation and gene expression are lacking except for one study on the effect of vinclozolin on DNA methylation and gene expression \[[@dvy005-B6], [@dvy005-B7]\].

Persistent organic pollutants such as polychlorinated biphenyls (PCBs) are ubiquitously distributed in the environment and exert a wide range of toxic effects. The most toxic PCBs are *non-ortho* substituted congeners (dioxin-like PCBs) such as 3, 3', 4, 4', 5-pentachlorobiphenyl (PCB126). There is accumulating evidence that exposure to PCBs can cause a number of metabolic, behavioral and neurodevelopmental defects. The mode of action of dioxin-like PCBs is well understood; it involves activation of aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor \[[@dvy005-B8]\]. There is extensive knowledge of target genes regulated by the AHR \[[@dvy005-B9]\], but there is very limited information on whether the effects of AHR ligands on these genes involve changes in DNA methylation. Recent studies have demonstrated an association between PCB exposure and altered DNA methylation in humans \[[@dvy005-B10]\]. In addition, exposure to dioxin-like PCBs has been shown to cause changes in DNMT gene expression and gene-specific DNA methylation \[[@dvy005-B15]\]. Very few studies have determined genome-wide changes in DNA methylation in response to AHR agonists \[[@dvy005-B21]\]. The objective of this study is to identify genome-wide changes in DNA methylation concomitant with gene expression patterns in the liver and brain tissues of zebrafish exposed to PCB126. We hypothesized that DNA methylation changes play a role in altered gene expression in response to PCB126 exposure.

Zebrafish is a well-established toxicology model system and has been used to study the developmental toxicity of dioxin-like PCBs \[[@dvy005-B22]\], as well as the latent effects of developmental exposure \[[@dvy005-B23], [@dvy005-B24]\]. The DNA methylomes of different life history stages of developing zebrafish, as well as adult tissues have been sequenced \[[@dvy005-B25]\]. We have previously shown that developmental exposure to the potent AHR ligand, 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD or dioxin) altered the expression of DNMTs and differentially methylated the CpG islands in the promoter regions of some AHR target genes in zebrafish \[[@dvy005-B29]\]. However, the relationship between genome-wide changes in DNA methylation and altered patterns of gene expression in response to any AHR ligand is unknown, in any model system. Our results demonstrate that PCB126 exposure alters DNA methylation across the genome with the majority of the sites localizing to the distal promoter regions in both liver and brain tissues. Transcriptional profiling suggests that there is very little concordance between these DNA methylation changes and gene expression patterns.

Materials and Methods
=====================

Experimental Animals
--------------------

Adult TL (Tupfel/Long fin mutations) strain of zebrafish was used in this study. The zebrafish were maintained in a 10 l tank (density of 2 fish per litre) at 28°C system water with a 14-h light, 10-h dark cycle. The fish were fed twice daily; morning feeding with freshly hatched brine shrimp (*Artemia salina*) and afternoon feeding with GEMMA Micro 300 microencapsulated diet (Skretting USA, Tooele, Utah). The procedures used in this study were approved by the Animal Care and Use Committee of the Woods Hole Oceanographic Institution.

PCB126 Exposure
---------------

Adult male and female zebrafish (6 months old) were exposed to either 10 nM PCB126 or solvent carrier (0.01% DMSO) in system water (475 mg/l Instant Ocean, 79 mg/l sodium bicarbonate and 53 mg/l calcium sulfate; pH 7.2) for 24 h. We chose a 24 h exposure period in order to ensure AHR activation in both liver and brain tissues. Exposures were carried out in 2 gallon capacity glass aquarium tanks in 5 l of water at density of 1 fish per 1.25 l of water. This concentration of PCB126 was chosen because it does not elicit any overt morphological defects, but induces gene expression changes. This concentration is also ten times lower than the concentration used in a previous study where zebrafish juveniles (∼2 months old) were exposed to PCB126 by a similar route of exposure \[[@dvy005-B30]\]. We chose 6 month old fish (standard length 23.5 ± 3.5 mm) for this experiment for practical reasons of dissecting liver and brain tissues. Zebrafish are considered as adults starting from 3 months of age to 2 years \[[@dvy005-B31]\].

Each treatment had 4 biological replicates (2 males and 2 females). At the end of the exposure, fish were transferred to clean water with constant aeration and heating and maintained for 7 days. Fish were not fed during the 24 h exposure period. During the 7 days post-exposure, the husbandry conditions were the same as described in the previous section. At 7 days post-exposure, fish were euthanized with MS-222 (150 mg/l) buffered with sodium bicarbonate (pH 7.2) prior to tissue sampling. We chose this experimental design in order to capture both primary and secondary changes in DNA methylation and gene expression. Liver and brain tissues were dissected and snap frozen in liquid nitrogen and stored at --80°C until nucleic acids were isolated.

Isolation of Total RNA and Genomic DNA
--------------------------------------

Simultaneous isolation of genomic DNA and total RNA was performed using the ZR-Duet™ DNA/RNA MiniPrep kit (Zymo Research, CA). RNA was treated with DNase during the isolation process. DNA and RNA were quantified using the Nanodrop Spectrophotometer. The quality of DNA and RNA was checked using the Agilent 4200 and 2200 TapeStation systems, respectively. The DNA and RNA integrity numbers of all samples were between 9 and 10.

Quantitative Real-Time PCR
--------------------------

Complementary DNA was synthesized from 1 μg total RNA using the iScript cDNA Synthesis Kit (Bio-Rad, CA). Quantitative PCR was performed with iQ SYBR Green Supermix in a MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad, CA). Real-time PCR primers used for amplifying β-actin were 5'-CAACAGAGAGAAGATGACACAGATCA-3' (Forward) and 5'-GTCACACCATCACCAGAGTCCATCAC-3' (Reverse). These primers amplify both β-actin paralogs (*actb1* and *actb2*). C*yp1a* forward and reverse primers were 5'-GCATTACGATACGTTCGATAAGGAC-3' and 5'-GCTCCGAATAGGTCATTGACGAT-3', respectively.

The PCR conditions used were 95°C for 3 min (1 cycle) and 95°C for 15 s/65°C for 1 min (40 cycles). At the end of each PCR run, a melt curve analysis was performed to ensure that only a single product was amplified. Three technical replicates were used for each sample. A no-template control was included on each plate to ensure the absence of background contamination. We did not observe any significant differences in β-actin levels between DMSO and PCB126 both in qPCR and in our RNAseq data. Relative expression was normalized to that of β-actin (2^--ΔC*t*^; where ΔC*t* = \[C*t*(*cyp1a*)--C*t*(*β-actin*)\]). One-way ANOVA was used to determine the effect of PCB126 on *cyp1a* induction (GraphPad Prism version 5.3). A probability level of *P* \< 0.05 was considered statistically significant.

Enhanced Reduced Representation Bisulfite Sequencing and Data Analysis
----------------------------------------------------------------------

Enhanced reduced representation bisulfite sequencing (eRRBS) library preparation and sequencing was conducted by ZymoResearch. Briefly, libraries were prepared from 200--500 ng of genomic DNA digested with 60 units of TaqαI and 30 units of MspI (New England Biolabs, MA) sequentially and then extracted with DNA Clean and Concentrator™-5 kit (ZymoResearch, CA). Fragments were ligated to pre-annealed adapters containing 5'-methylcytosine instead of cytosine according to Illumina's specified guidelines. Adaptor-ligated fragments of 150--250 bp and 250--350 bp in size were recovered from a 2.5% NuSieve 1 : 1 agarose gel (Zymoclean™ Gel DNA Recovery Kit). The fragments were then bisulfite-treated using the EZ DNA Methylation-Lightning™ Kit. Preparative-scale PCR was performed and the resulting products were purified and 50 bp paired end (PE) sequencing was performed on an Illumina HiSeq2500 platform. Sequence reads from eRRBS libraries were identified using standard Illumina base-calling software.

Raw reads were pre-processed using TrimGalore and aligned to the zebrafish genome (GRCz10) using the Bismark alignment software \[[@dvy005-B32]\] with maximum 2 mismatches, and only uniquely aligned reads were retained for subsequent analysis. Index files were generated using the *bismark_genome_preparation* command and the entire reference genome. The *--non_directional* parameter was applied while running Bismark. All other parameters were set to default. Filled-in nucleotides were trimmed off when doing methylation calling. The methylation level of each sampled cytosine was estimated as the number of reads reporting a C, divided by the total number of reads reporting a C or T.

Differentially methylated CpG regions were analysed using methylKit \[[@dvy005-B33]\]. Sex of the fish was used as a co-variate in the analysis. Briefly, the numbers of methylated and unmethylated CpG sites were counted for each region and descriptive statistics such as read coverage and percentage methylation were calculated for each sample. Samples were filtered based on read coverage and any reads with \<10x coverage were discarded. We further filtered the reads by only selecting the CpG sites covered in all the samples. To determine differential methylation, we used the tiling window approach with a 300 bp window length and 300 bp step-size. The logistic regression method was used to calculate *P*-values. We empirically determined that the 300 bp window length was appropriate in our case as the majority of the tiles had approximately the same number of CpG sites and the DMRs were not fragmented into multiple small regions. The SLIM method \[[@dvy005-B34]\] was used to calculate *q*-values. We used a *q*-value of less than 0.01 and percent methylation difference larger than 25% as the statistical cutoff for determining DMRs. We used the Genomation package \[[@dvy005-B35]\] to classify the DMRs into different genomic regions. Genomic coordinates of zebrafish refseq genes, CpG islands and repeat sequences were downloaded from the UCSC genome browser. CpG shores were defined as 2000 bp flanking regions on upstream and downstream of a given CpG island.

DMR Gene Ontology Enrichment Analysis
-------------------------------------

We used Genomic Regions Enrichment of Annotations Tool (GREAT) to associate DMRs with genes \[[@dvy005-B36]\]. GREAT predicts gene functions of *cis* regulatory elements by assigning each gene a regulatory domain. To use GREAT, we converted the genomic coordinates of DMRs from GRCz10 version to Zv9 version of the genome using the UCSC genome browser liftOver utility (<https://genome.ucsc.edu/cgi-bin/hgLiftOver>). We used default parameters with a basal domain that extends 5 kb upstream and 1 kb downstream of the TSS and conducted gene ontology (GO) (biological process and molecular function) enrichment analysis.

RNA Sequencing and Data Analysis
--------------------------------

Unstranded RNAseq library preparation using the Illumina TruSeq total RNA library prep kit and 50 bp single-ends sequencing on the HiSeq2000 platform were performed at the Tufts University Core Facility. Raw data files were assessed for quality using FastQC \[[@dvy005-B37]\] and pre-processed as described previously \[[@dvy005-B38]\]. Pre-processed reads were mapped to the genome. We used Ensembl version 84 (GRCz10) of the zebrafish genome and annotations (gtf) in this analysis \[[@dvy005-B39]\]. HTSeq-count was used to obtain the number of reads mapped to annotated regions of the genome \[[@dvy005-B40]\]. Statistical analysis was conducted using edgeR, a Bioconductor package \[[@dvy005-B41]\], using sex as an independent variable. Only genes with false discovery rate (FDR) of less than 5% were considered to be differentially expressed. Raw data has been deposited into Gene Expression Omnibus (accession number GSE104221).

GO analysis of differentially expressed genes (DEGs) was done using gProfiler \[[@dvy005-B42]\]. Zebrafish ensembl IDs were used as input and Bonferroni correction for multiple testing (*P*-value \<0.05) was used while determining the fold enrichment. To understand the relationship between GO terms, Directed Acyclic Graphs of significantly enriched GO terms were drawn using GOView (webgestalt.org/GOView).

Comparing DNA Methylation Changes with Gene Expression
------------------------------------------------------

To determine the overlap between DMRs and gene expression, we compared the gene annotation of DMRs obtained from GREAT analysis with the DEGs determined by RNA-seq. For the set of overlapping genes, we determined the Spearman's correlation coefficient between difference in methylation of the DMR and the altered expression of the target gene.

Results
=======

*Cyp1a* Gene Expression
-----------------------

To confirm the activation of AHR by PCB126, we quantified *cyp1a* gene expression using quantitative real-time PCR ([Fig. 1](#dvy005-F1){ref-type="fig"}). We observed 48-fold and 672-fold increase in *cyp1a* expression in liver and brain, respectively. The higher fold increase in *cyp1a* expression in the brain compared to liver is partly due to a lower basal expression.

![PCB126-induced *cyp1a* gene expression in the liver (**A**) and brain (**B**). *Cyp1a* expression relative to the reference gene was calculated using the delta C*t* method. β-Actin was used as a reference gene. \* Represents significant difference from DMSO control (One-way ANOVA; *P* \< 0.01)](dvy005f1){#dvy005-F1}

DNA Methylation Profiling
-------------------------

We used enhanced RRBS (eRRBS) to identify DMRs in response to PCB126 exposure. eRRBS is a modified version of RRBS that includes fragments of MspI (C\^CG_G) and Taqα1 (A\^CG_T) restriction enzyme digest and captures CpG sites beyond the CpG islands \[[@dvy005-B43]\]. RRBS and eRRBS have been previously used to profile baseline DNA methylation in adult zebrafish tissues \[[@dvy005-B28], [@dvy005-B44]\] and in response to toxicants \[[@dvy005-B45]\].

Using eRRBS, we sequenced an average of 34 million and 31.66 million paired-ends reads from liver and brain samples, respectively. The bisulfite conversion efficiency was 98--99%. The mapping efficiency of these reads to the bisulfite converted zebrafish genome was between 36% and 38%, which is comparable to previously published studies in zebrafish \[[@dvy005-B28], [@dvy005-B44]\]. On average, 257 million cytosines were sequenced. Of these 28.5 and 15.2 million were methylated and unmethylated, respectively, in a CpG context. In both liver and brain tissues, we sequenced approximately 1.25 million unique CpGs per sample with 10x coverage. A detailed summary of the number of CpGs and their coverage is provided in the [Supplementary Material (eRRBS_summary_statistics.xlsx)](#sup1){ref-type="supplementary-material"}.

Using a 300-bp tiling window size, we observed 125 008 unique tiles that were represented in all eight liver samples. The number of unique 300 bp tiles that were shared among all eight brain samples was 103 673. Based on the analysis of all the samples, the genome wide methylation level in the liver and brain was found to be 66.87% and 63.12%, respectively. Methylation level was low in the promoter regions and CpG islands ([Fig. 2A and B](#dvy005-F2){ref-type="fig"}). Annotation of these tiles revealed that the majority of the CpGs are located in the distal promoter regions in both tissues ([Fig. 2C](#dvy005-F2){ref-type="fig"}). Only 8% of the features are associated with CpG islands and shores ([Fig. 2C](#dvy005-F2){ref-type="fig"}).

![Tissue-specific DNA methylation profiles and their genomic location. Percentage of methylation levels in the proximal promoter regions (**A**) and CpG islands (**B**) in the liver and brain are plotted. (**C**) Percentage of 300 bp tiles overlapping with different genomic regions. These plots are based on the tiles represented in all samples. Proximal (up to 5 kb upstream) and distal promoter (\>5 kb) regions are classified based on the distance from the transcriptional start site](dvy005f2){#dvy005-F2}

PCB126-Induced Changes in DNA Methylation in the Liver
------------------------------------------------------

Differential methylation analysis revealed a total of 573 DMRs in the liver in response to PCB126 exposure ([Fig. 3A](#dvy005-F3){ref-type="fig"}), out of which 327 were hypomethylated and 246 were hypermethylated. Only 59 hypomethylated DMRs (15% of total) and 47 hypermethylated DMRs (19% of total) showed a percent methylation difference larger than or equal to 40%. DMRs were distributed throughout the genome with no discernable patterns in their chromosomal location. The complete list of liver DMRs is provided in the [Supplementary Material (Liver_DMRs.xlsx)](#sup1){ref-type="supplementary-material"}.

![PCB126-induced tissue-specific changes in DNA methylation. Volcano plots showing DMRs in response to PCB126 exposure in the liver (**A**) and brain (**B**). Percent methylation difference (x-axis) between PCB126 and Control are plotted against *q*-value (y-axis). Red vertical lines represent the 25% methylation difference and the blue horizontal line represents a *q*-value of 0.05, which are used as a statistical cutoff in differential methylation analysis. Each green and red spot represents a statistically significant hypo and hypermethylated region, respectively](dvy005f3){#dvy005-F3}

The hypermethylated DMRs were enriched in GO biological process terms such as otic placode development, positive regulation of *Wnt* receptor signaling pathway and integrin-mediated signaling pathway ([Fig. 4A](#dvy005-F4){ref-type="fig"}). The enriched GO molecular function terms include dopamine beta-monoxygenase activity, inositol 1, 4, 5-trisphosphate 3-kinase (IP~3~ 3-kinase/IP3K) and GABA receptor activity ([Fig. 4B](#dvy005-F4){ref-type="fig"}). The complete list of all GO terms, their fold enrichment, the list of genes associated with each GO term and the DMR distance from the transcriptional start site are provided in the [Supplementary Material (Liver_DMR_GO_analysis.xlsx)](#sup1){ref-type="supplementary-material"}.

![GO term analysis of DMRs in the liver (**A**, **C**) and brain (**B**, **D**). Top panel represents GO biological process terms and the bottom panel contains the GO molecular function terms. GO term analysis was performed on DMRs using GREAT. Only statistically significant GO terms are shown. The fold enrichment of GO terms and the genes associated with each term are provided in the [Supplementary Material](#sup1){ref-type="supplementary-material"}](dvy005f4){#dvy005-F4}

GO analysis of hypomethylated DMRs revealed enrichment of biological process terms such as negative regulation of apoptosis, secretion, regulation of collateral sprouting and thyroid gland development ([Fig. 4A](#dvy005-F4){ref-type="fig"}). The hypomethylated DMRs were enriched in GO molecular function terms sugar-phosphatase activity, transferase activity, transferring sulfur-containing groups, thyroxine 5'-deiodinase activity, cGMP binding, intracellular ligand-gated ion channel activity and heparan sulfate sulfotransferase activity ([Fig. 4B](#dvy005-F4){ref-type="fig"}).

PCB126-Induced Changes in DNA Methylation in the Brain
------------------------------------------------------

In the brain, a total of 481 DMRs were observed with 294 hypomethylated and 187 hypermethylated regions ([Fig. 3B](#dvy005-F3){ref-type="fig"}). Only a small proportion of these (19% of hypomethylated and 14% of hypermethylated) showed a percent methylation difference larger than 40%. Similar to the liver DMRs, the DMRs in the brain were distributed randomly along chromosomes. The complete list of brain DMRs is provided in the [Supplementary Material (Brain_DMRs.xlsx)](#sup1){ref-type="supplementary-material"}.

Hypermethylated DMRs in the brain showed significant enrichment of two GO molecular function terms (cyclin-dependent protein kinase 5 activator activity and protein kinase activator activity) and three biological process terms (piwi-interacting RNA (piRNA) metabolic process, regulation of receptor activity and monocarboxylic acid biosynthetic process) ([Fig. 4C](#dvy005-F4){ref-type="fig"}). On the other hand, the hypomethylated DMRs were enriched in GO molecular function terms such as acetylglucosaminyltransferase activity, GABA receptor activity and transcription regulatory region DNA binding ([Fig. 4D](#dvy005-F4){ref-type="fig"}). The complete list of all GO terms, their fold enrichment, the list of genes associated with each GO term and the DMR distance from the transcriptional start site are provided in the [Supplementary Material (Brain_DMR_GO_analysis.xlsx)](#sup1){ref-type="supplementary-material"}.

PCB126-Induced Transcriptional Changes
--------------------------------------

We obtained an average of 32.3 and 30.6 million raw reads from liver and brain samples, respectively. Of these, 83% (liver) and 88% (brain) of the reads were mapped uniquely to the zebrafish genome. Multi-dimensional scaling indicated two liver samples \[one control (male) and one PCB126 treated (female)\] to be outliers and hence these were not included in the differential expression analysis. These two samples had only 68% and 74% of the reads uniquely mapped to the zebrafish genome. The summary of the raw data is presented in the [Supplemental Material (RNAseq_Summary.xlsx)](#sup1){ref-type="supplementary-material"}.

There were a total of 585 and 1715 DEGs in the liver and brain, respectively ([Fig. 5](#dvy005-F5){ref-type="fig"}). Among the 585 DEGs in the liver, 300 were upregulated and 285 were downregulated. All DEGs in the liver were altered by a fold change of 2 or higher even with a FDR of 10% as a statistical cutoff ([Supplementary Material -- Liver_DEGs.xlsx](#sup1){ref-type="supplementary-material"}). The upregulated genes were enriched in GO terms such as response to xenobiotic stimulus (biological process), and acrosin binding (molecular function). Many of the upregulated genes are known AHR target genes ([Table 1](#dvy005-T1){ref-type="table"}). Cell cycle and glutathione metabolism are the two KEGG pathways enriched among the upregulated genes. The downregulated genes in the liver represent pathways associated with sterol, ion, oxygen and heme transport activity. The GO terms and the associated genes for both up and downregulated genes in the liver are shown in [Table 2](#dvy005-T2){ref-type="table"}. Table 1:Representative xenobiotic responsive genes differentially expressed in liver and brain in response to PCB126 exposureGene nameGene symbolLiverBrainlogFCFDRlogFCFDRAHR repressor a*ahrra*10.6777.21E--463.8501.12E--02AHR repressor b*ahrrb*7.5004.89E--042.6693.68E--02AHR interacting protein*aip*0.5533.90E--02AHR nuclear translocator-like 1a*arntl1a*--0.6942.71E--02AHR nuclear translocator-like 1b*arntl1b*--0.7923.38E--02AHR nuclear translocator-like 2*arntl2*--1.7582.75E--03--1.0332.53E--02Cytochrome P4501a*cyp1a*5.4203.40E--208.5718.60E--85Cytochrome P4501b1*cyp1b1*7.7501.35E--161.8343.11E--03Cytochrome P450, family 1, subfamily C, polypeptide 1*cyp1c1*5.4336.30E--174.7457.26E--06Cytochrome P450, family 1, subfamily C, polypeptide 2*cyp1c2*2.8872.44E--063.0586.81E--03Cytochrome P450, family 2, subfamily AA, polypeptide 12*cyp2aa12*1.4433.88E--02Cytochrome P450, family 2, subfamily AA, polypeptide 4*cyp2aa4*2.6622.04E--02Cytochrome P450, family 2, subfamily K, polypeptide 22*cyp2k22*--5.6542.50E--02Cytochrome P450, family 2, subfamily K, polypeptide 31*cyp2k31*--5.1693.10E--07Cytochrome P450, family 2, subfamily K, polypeptide 6*cyp2k6*8.6071.52E--02Cytochrome P450, family 2, subfamily X, polypeptide 10.2*cyp2x10.2*3.4952.32E--10Cytochrome P450, family 2, subfamily AD, polypeptide 3*cyp2ad3*1.0551.79E--02Cytochrome P450, family 2, subfamily P, polypeptide 6*cyp2p6*1.0056.51E--03Cytochrome P450, family 2, subfamily V, polypeptide 1*cyp2v1*1.3489.56E--03Cytochrome P450, family 26, subfamily b, polypeptide 1*cyp26b1*0.9859.56E--03Glutathione S-transferase theta 1b*gstt1b*1.3494.30E--02Microsomal glutathione S-transferase 3b*mgst3b*2.0507.38E--040.7621.18E--02Glutathione S-transferase theta 1a*gstt1a*3.9833.73E--02Glutathione S-transferase mu, tandem duplicate 1*gstm.1*0.6193.15E--02Glutathione S-transferase rho*gstr*0.7683.90E--02Glutathione S-transferase pi 1*gstp1*0.8833.43E--02Glutamate-cysteine ligase, modifier subunit*gclm*1.7791.52E--03Glutathione reductase*gsr*1.4983.79E--03Glucose-6-phosphate dehydrogenase*g6pd*1.6101.96E--02NAD(P)H dehydrogenase, quinone 1*nqo1*1.9513.42E--02Kelch-like ECH-associated protein 1b*keap1b*1.3084.11E--02UDP glucuronosyltransferase 1 family, polypeptide B5*ugt1b5*1.6332.20E--02UDP glucuronosyltransferase 1 family, polypeptide B1*ugt1b1*1.6676.72E--03UDP glucuronosyltransferase 1 family, polypeptide B2*ugt1b2*--2.2173.98E--02UDP glucuronosyltransferase 1 family, polypeptide B7*ugt1b7*--2.7798.30E--05UDP glucuronosyltransferase 5 family, polypeptide C2*ugt5c2*--2.0991.03E--02UDP glucuronosyltransferase 1 family, polypeptide A6*ugt1a6*4.2513.13E--02Phosphogluconate dehydrogenase*pgd*1.8564.99E--03Table 2:GO and KEGG pathway analysis of DEGs in the liver (A) Upregulated genes and (B) downregulated genes in the liver were analysed separately for enrichment of GO biological process and molecular function terms and KEGG pathwaysATerm IDNameAdjusted *P*-value GO: 0009410Response to xenobiotic stimulus0.002 GO: 0032190Acrosin binding0.000152**KEGG** KEGG: 04110Cell cycle0.0000199BTerm IDNameAdjusted *P*-value**Biological process** GO: 0015669Gas transport0.0000129 GO: 0006820Anion transport0.000632 GO: 0010873Positive regulation of cholesterol esterification0.00185 GO: 0033700Phospholipid efflux0.00185 GO: 0065005Protein-lipid complex assembly0.00185 GO: 0055088Lipid homeostasis0.00365 GO: 0006695Cholesterol biosynthetic process0.0141**Molecular function** GO: 0015248Sterol transporter activity0.00123 GO: 0060228Phosphatidylcholine-sterol-O-acyltransferase activator activity0.00185 GO: 0005344Oxygen transporter activity0.00365 GO: 0019825Oxygen binding0.00365 GO: 0020037Heme binding0.0376 GO: 0015485Cholesterol binding0.0417 GO: 0005215Transporter activity0.0463**KEGG** KEGG: 00910Nitrogen metabolism0.0386

![Tissue-specific gene expression changes. MA plots showing the DEGs in the liver (**A**) and brain (**B**). Horizontal blue lines represent fold change of ± 2. Each red spot represent a statistically differentially expressed gene](dvy005f5){#dvy005-F5}

In the brain, PCB126 exposure resulted in the differential expression of 1715 genes. Among these 899 genes were upregulated and 816 genes were downregulated ([Fig. 5](#dvy005-F5){ref-type="fig"}; [Supplementary Material -- Brain_DEGs.xlsx](#sup1){ref-type="supplementary-material"}). Similar to the responses in the liver, genes associated with xenobiotic metabolism were upregulated in the brain ([Table 1](#dvy005-T1){ref-type="table"}). The GO terms (molecular function) enriched among the upregulated genes include acrosin binding, actin binding and ribosomal constituents. The upregulated KEGG pathway terms include metabolism of xenobiotics by cytochrome P450 and ribosome. The downregulated genes in the brain were enriched in GO terms (molecular function) such as nucleoside-triphosphate activity, structural constituent of cytoskeleton and tubulin binding. KEGG terms represented include dorso-ventral axis formation, FoxO signaling pathway, ErbB signaling pathway and mRNA surveillance pathway. The GO terms and the associated genes for both up and downregulated genes in the brain are shown in [Table 3](#dvy005-T3){ref-type="table"}. Table 3:GO and KEGG pathway analysis of DEGs in the brain (A) Upregulated genes and (B) downregulated genes in the brain were analysed separately for enrichment of GO biological process and molecular funtion terms and KEGG pathwaysATerm IDGO termAdjusted *P*-value**Biological process** GO: 0006412Translation0.0000253 GO: 0009410Response to xenobiotic stimulus0.0000854 GO: 0003012Muscle system process0.000151 GO: 0060326Cell chemotaxis0.00487 GO: 0045861Negative regulation of proteolysis0.0158 GO: 0043902Positive regulation of multi-organism process0.0161 GO: 0009605Response to external stimulus0.024**Molecular function** GO: 0003735Structural constituent of ribosome9.07E--13 GO: 0003779Actin binding0.0000803 GO: 0032190Acrosin binding0.0299**KEGG** KEGG: 03010Ribosome1.66E--11 KEGG: 00980Metabolism of xenobiotics by cytochrome P4500.000786BTerm IDGO termAdjusted *P*-value**Biological process** GO: 0016043Cellular component organization2.28E--15 GO: 0060627Regulation of vesicle-mediated transport0.00154 GO: 0043087Regulation of GTPase activity0.0023 GO: 0006836Neurotransmitter transport0.00343 GO: 0035556Intracellular signal transduction0.00659**Molecular function** GO: 0000902Cell morphogenesis0.0188 GO: 0017111Nucleoside-triphosphatase activity0.00641 GO: 0015631Tubulin binding6.44E--11 GO: 0008047Enzyme activator activity0.00309 GO: 0005200Structural constituent of cytoskeleton0.00375 GO: 0098772Molecular function regulator0.0042**KEGG** KEGG: 04320Dorso-ventral axis formation0.0043 KEGG: 04068FoxO signaling pathway0.0147 KEGG: 03015mRNA surveillance pathway0.0167 KEGG: 04012ErbB signaling pathway0.0368

Relationship between DMRs and Altered Gene Expression
-----------------------------------------------------

There was very little correlation between DMRs and gene expression patterns. In the liver, only nine genes were both differentially methylated and differentially expressed. Of these, six genes showed the expected inverse relationship between DNA methylation and gene expression. In the brain, 33 genes showed both altered methylation and altered gene expression and only 12 of these were inversely related ([Table 4](#dvy005-T4){ref-type="table"}). For both liver and brain, there was not a significant correlation between the degree of altered DNA methylation and the degree of altered gene expression (Spearman *r*^2^ = 0.2719 for liver and 0.0078 for brain). Table 4:Relationship between DMRs and DEGs (A) List of genes in the liver (A) and brain (B) that are both differentially methylated and differentially expressed. Spearman correlation coefficient was not statistically significant (*r*^2^ = 0.2719 for liver and 0.0078 for brain). There is an inverse relationship between DNA methylation (Meth. diff) and gene expression (logFC) for the genes highlighted in red![](dvy005_t4.jpg)

Discussion
==========

AHR is a ligand activated transcription factor known to regulate a wide variety of target genes upon PCB126 exposure. The results indicate that PCB126 exposure altered DNA methylation patterns mostly in the distal promoter regions (\>10 kb). Transcriptomic profiling revealed classical responses to dioxin-like PCBs including upregulation of xenobiotic metabolism genes and downregulation of genes associated with growth and energy metabolism. However, the genes associated with DMRs represent diverse physiological pathways in both tissues. We observed very little overlap between DEGs and the genes associated with DMRs, suggesting distinct effects of PCB126 on DNA methylation and gene expression. We attempted to capture both the primary and secondary changes in DNA methylation and gene expression by sampling at 7 days post-exposure. As DNA methylation and transcription are dynamic processes, our results represent a snapshot of the changes. In order to capture the relationship between these processes multiple time points need to be analysed.

The effects of dioxin and dioxin-like PCBs on DNA methylation have previously been demonstrated but most of these studies have used gene or locus-specific methods to measure DNA methylation \[[@dvy005-B15], [@dvy005-B20], [@dvy005-B29]\]. Using eRRBS we show that there are strikingly high levels (\>60%) of DNA methylation in the distal promoter regions in zebrafish compared to other species \[[@dvy005-B46]\]. Our results demonstrate differential methylation in response to PCB126 exposure at multiple loci distributed throughout the genome in both tissues. We could not detect any sex-specific differences, possibly due to small sample size (*n* = 2) and lack of statistical power.

Differential Methylation in the Liver
-------------------------------------

In the liver, DMRs are associated with a variety of genes including transcription factors, receptors, transporters, cell adhesion molecules, endocrine and metabolic enzymes. Most of the genes play an important role in hepatic development and regeneration in response to injury. For instance, we observed PCB126-induced hypermethylation of *sox9a* and *sox9b genes*, which encode transcription factors critical for normal development. In mammals, SOX9 is responsible for maintaining homeostasis in the liver and the regenerative capacity is dependent on SOX9-positive hepatic progenitor cells \[[@dvy005-B47]\]. Similarly, in the zebrafish regeneration model, ablation of hepatocytes causes transdifferentiation of biliary cells into hepatocytes and this process is blocked in *sox9b* mutants \[[@dvy005-B48]\], suggesting an important role in liver regeneration. Previous studies have shown downregulation of *sox9b* expression with AHR agonists in zebrafish embryos and in regenerating tissues (caudal fin) \[[@dvy005-B49]\]. However, we did not observe differential expression of *sox9b* in either the liver or brain, suggesting tissue-specific differences in its regulation. As SOX9 genes are master regulators of cell fate and tissue morphogenesis, it is possible that their expression is regulated by multiple mechanisms including DNA methylation.

One such mechanism of *sox9b* regulation is by non-coding RNA. A recent study has demonstrated that a long intervening non-coding RNA (lincRNA; si: ch1073--384e4.1) regulates the expression of *sox9b* in zebrafish embryos \[[@dvy005-B53]\]. We also observed significant upregulation of this lincRNA in response to PCB126 exposure (4.5 log FC; FDR 6.03E--12), suggesting multiple modes of action of AHR agonists in altering *sox9b* expression in zebrafish. Garcia *et al*. \[[@dvy005-B53]\] also demonstrated that this lincRNA expression is AHR-dependent and is required for *sox9b* expression during normal development.

Other hypermethylated genes that are critical for liver growth and regeneration include hepatocyte growth factor (*hgfa*) and fibroblast growth factor 8a (*fgf8a*). *Hgfa* is an acute phase protein induced in the liver in response to injury and is required for liver regeneration \[[@dvy005-B54], [@dvy005-B55]\]. *Fgf8a* is a member of the FGF family of growth factors and a morphogen \[[@dvy005-B56]\]. Given the role of these genes in repair and regeneration, it is possible that hypermethylation (and therefore downregulated expression) of these genes exacerbate injury by reduced regeneration.

Another important enriched pathway among the hypermethylated DMRs includes thyroid hormone signaling. We observed hypermethylation of paired box 8 (*pax8*) and iodothyronine deiodinase genes (*dio2 and dio3a*). *Pax8* is a transcription factor involved in thyroid differentiation and its altered expression by either mutations or epigenetic modifications disrupts thyroid morphogenesis leading to a variety of phenotypes ranging from thyroid agenesis, ectopia and hypoplasia \[[@dvy005-B57]\]. *Dio2* catalyzes the conversion of prohormone thyroxine (T4) to the bioactive thyroid hormone (T3), and *dio3a* converts T4 and T3 into inactive metabolites. As liver has an important role in thyroid hormone metabolism and hypothyroidism is linked to liver diseases \[[@dvy005-B58]\], it is possible that altered methylation of these genes could affect downstream signaling. It is very well documented that dioxins and dioxin-like PCBs cause hypothyroidism by altering thyroid hormone levels \[[@dvy005-B59]\]. Concomitant with hypermethylation of *dio2*, we observed a decrease in its expression, suggesting a potential mechanism of action of PCB126 in causing hypothyroidism. In addition, we also observed hypermethylation of genes that encode sulfotransferases (*gal3st1, hs3st2, hs3st4, hs6st1a, ndst3, nfs1, sult6b1*), key players in the metabolism of xenobiotics, drugs and endogenous hormones. Hydroxylated PCBs, the metabolic byproducts of PCBs, disrupt endocrine signaling by inhibiting sulfotransferases \[[@dvy005-B63]\]. Indeed there is an association between increased body burden of hydroxylated PCBs and altered thyroid hormone status in humans \[[@dvy005-B64]\]. It remains to be determined if altered methylation of these genes is a potential mechanism of action of dioxin-like PCBs. Our RNAseq data do not reveal differential expression of these genes.

We also observed several hypomethylated DMRs in the liver and enrichment analysis revealed these DMRs to be associated with transcription factors belonging to the homeobox family (*dmbx1b, pax2a, pbx2, pbx4, lhx9*), nuclear receptor superfamily (*nr2f2*) and others (*gata5*). We did not find any studies demonstrating the involvement of these transcription factors in liver metabolism or their altered DNA methylation or gene expression in response to dioxin-like PCB exposure. However, these transcription factors are important players in early cellular differentiation suggesting that altered methylation could affect tissue differentiation and regeneration capacity in response to injury.

Differential Methylation in the Brain
-------------------------------------

In contrast to the liver, hypermethylated DMRs in the brain did not show significant enrichment of many GO terms. Among the enriched GO terms, one that is particularly interesting is piRNA metabolic process. piRNAs are 23--32 nucleotide single stranded RNA molecules derived from the intergenic regions or 3' untranslated regions of mRNAs. They are involved in transposable element (TE) repression \[[@dvy005-B65]\] and preserving genomic integrity \[[@dvy005-B66], [@dvy005-B67]\]. piRNAs were originally discovered in the germline, but their presence and function in somatic cells including neurons has been reported \[[@dvy005-B68], [@dvy005-B69]\]. Defects in piRNA production result in TE de-repression and cell death. We observed hypomethylation of HEN methyltransferase (*henmt1*) and tudor domain containing protein 1 (*tdrd1*) genes, key players in piRNA biogenesis. *Henmt1* adds a 2'-O-methyl group at the 3'-end of piRNAs and protects the 3'-end of piRNAs from degradation. In zebrafish, loss of *henmt1* has been shown to reduce piRNA content in oocytes and cause female sterility. *Tdrd1* acts as a molecular scaffold for piwi proteins and is required for proper functioning of the piRNA pathway. If hypomethylation of these genes could lead to increased gene expression and subsequently to an increase in piRNA production, it is possible that this is in response to an increase in TE re-activation and retrotransposition in the brain resulting from PCB126 exposure. We observed significant induction of *tdrd1* expression in the brain (logFC 4.03; FDR 0.01) suggesting increased piRNA biosynthesis to suppress TE activation. Previous studies have demonstrated that xenobiotics can cause TE activation \[[@dvy005-B70], [@dvy005-B71]\].

In the brain, many of the hypomethylated DMRs are associated with genes related to the Wnt/β -- catenin signaling pathway, crucial for the formation of the blood-brain barrier (BBB) \[[@dvy005-B72]\]. BBB is a semi-permeable barrier that restricts the movement of ions and molecules between the blood and brain, and its disruption can lead to inflammation. We observed hypomethylation of a Wnt ligand (*Wnt4a*), a Wnt signaling antagonist (*dkk1a*) and associated genes (*ctnnbip1, ascl1a*). In addition, we observed hypomethylation of cell adhesion genes \[cadherins (*cdh2, cdh6*) and protocadherins (*pcdh10b, pcdh15a, pcdh17, pcdh18b, pcdh1a, pcdh2g12*)\], which are modulated by Wnt/β -- catenin signaling. Cell adhesion genes are critical for the development and maintenance of proper vascular networks such as the BBB \[[@dvy005-B73]\]. It is not yet clear how hypomethylation of these gene regulatory regions can alter their expression. We did not observe differential expression of these genes in our RNAseq data, but other cell adhesion genes (*cdh2, cdh7, cdh17, cdh18a, pcdh2g5*) were differentially expressed. Previous research in murine models has shown that endothelial cells and astrocytes are targets of AHR-dependent TCDD toxicity \[[@dvy005-B74]\].

It remains to be determined how DNA methylation is regulated by AHR ligands. We have previously demonstrated that TCDD exposure alters DNMT gene expression patterns in developing embryos. Furthermore, we have shown *in vitro* that XREs in the DNMT proximal promoter regions influence DNMT expression \[[@dvy005-B29]\]. However, further studies are necessary to determine the mechanism of action of AHR activation in altering genome-wide DNA methylation patterns. We hypothesize that AHR activation alters the accessibility of DNA to DNMTs by altering the chromatin state.

PCB126 Induced Transcriptional Responses
----------------------------------------

We observed classical responses to PCB126 exposure in the liver and brain, where genes associated with xenobiotic metabolism were upregulated. Almost all of these are AHR target genes and have been shown previously to be altered by dioxins and dioxin-like PCBs in a variety of animals including zebrafish ([Table 1](#dvy005-T1){ref-type="table"}). In addition to cytochrome P450s, several oxidative stress response (OSR) genes were upregulated in both tissues. Glutathione (GSH) is critical for intracellular redox homeostasis and protects against oxidative damage caused by reactive oxygen species. It is well established that dioxin and dioxin-like PCBs contribute to oxidative stress \[[@dvy005-B75]\]. In this study, upregulation of OSR genes suggest that PCB126-exposed fish are trying to maintain cellular redox balance.

PCB126 exposure downregulated the expression of several genes encoding lipid-binding and transport proteins in the liver including apolipoproteins (*apoa1a, apoa4b.2, apoba, apoea, apoeb, apol6*), fatty acid binding proteins (*fabp1b.1, fabp2*) and solute carriers. AHR-mediated disruption of hepatic lipid metabolism has been well documented and altered expression of transport proteins is the hallmark of dioxin-induced hepatic inflammation, non-alcoholic fatty liver disease and steatosis \[[@dvy005-B76]\]. Our results agree with these findings that exposure to dioxin-like PCBs alters lipid metabolism by altering the expression of lipid transport proteins and suggest that the effects of PCBs on lipid homeostasis are conserved among vertebrates. We also observed downregulation of genes encoding heme-binding proteins (*cyp2k31, ido1, cyp2k22, hbba1, hbaa1, hbba1, hbaa2* and *PXDN*) in the liver. Heme is critical for oxygen transport, energy metabolism and drug biotransformation, and previous studies have shown that exposure to AHR agonists' increases cellular heme levels to compensate for the increased demand (e.g. cyp450 induction). Downregulation of these genes suggests reduced demand for heme or dysregulation of the compensatory mechanism potentially leading to metabolic disruption.

In the brain, we observed a relatively large number of DEGs compared to the liver suggesting that the brain is sensitive to exposure to environmental chemicals, particularly the neurotoxic effects of dioxin-like PCBs. We recently reported similar findings where developmental exposure to low levels of PCB126 altered the expression of thousands of genes in the adult brain \[[@dvy005-B77]\]. The differences in the sensitivity of tissues to PCB exposure at the molecular level are yet to be determined. In addition to the induction of xenobiotic response genes, we observed upregulation of a large number of ribosomal genes. This is in contrast to our previous observation that developmental exposure to PCB126 caused downregulation of ribosomal genes in the adult zebrafish brain \[[@dvy005-B38]\], sugggesting that the effects on gene expression vary depending on the duration and dose of exposure as well as the life stage at which the exposure has occurred. Ribosome biogenesis and protein synthesis are essential for cellular differentiation and proliferation and any alterations to these processes can severely impair cell growth. It has been shown that xenobiotics, nutrient depletion and hypoxia can affect ribosome biogenesis leading to ribosomal stress, a condition where unassembled ribosomal proteins are accumulated \[[@dvy005-B78]\]. Some ribosomal genes are shown to induce the p53 pathway in response to ribosomal stress. Further studies are necessary to understand the functional significance of the upregulation of ribosomal genes in PCB-induced toxicity.

In addition to the potential effects on ribosome biogenesis, PCB126 exposure downregulated genes associated with neurotransmitter transport, cytoskeletal network and genes involved in FoxO, ErbB and mRNA surveillance pathways. FoxO and ErbB signaling pathways regulate diverse processes including proliferation, differentiation, apoptosis, glucose metabolism and OSR.

Correlation between Altered DNA Methylation and Altered Gene Expression
-----------------------------------------------------------------------

One of the important findings from this study is that there is very little correlation between differential methylation and gene expression. Similar observations have been made in other recent studies in different model systems \[[@dvy005-B4], [@dvy005-B5], [@dvy005-B79]\] suggesting a complex relationship between DNA methylation and gene expression. Some of the potential reasons for the lack of high degree of correlation between DNA methylation and gene expression could be due to the experimental design and bisulfite sequencing approach used in this study. As DNA methylation changes precede gene expression changes, it is possible that one sampling time point may not be adequate to correlate the changes. In addition, primary and secondary gene expression changes in response to PCB exposure might be under different genetic and epigenetic regulatory mechanisms. Futhermore, the sample size is relatively small and biological variability might be confounding the results. Even though the eRRBS approach used in this study is powerful enough to capture the GC-rich genomic loci, there are several gene promoters that are GC-poor and are not captured using this approach. Future attempts to determine the correlation between DNA methylation and gene expression should consider sampling times carefully and use WGBS to capture majority of the GC loci in the genome.

Among the small number of genes that showed correlation include serotonin receptor (*htr1aa*), vitellogenin (*vtg1*), deiodinase 2(*dio2*), a monoxygenase (*ywhag1*) and a signaling adaptor molecule (*baiap2a*) in the liver. These genes play important roles not only in hepatic function but also regulate growth and reproduction. Similarly, the genes that showed correlation in the brain include a neurotransmitter receptor (*grm8a*), transcription factor (*klf2b*), chaperones (*pfdn5, lrpap1*), transmembrane glycoprotein (*pmp22a*) and a few uncharacterized genes. Some of these genes have been shown to be altered by PCBs, but there is no evidence suggesting their regulation by DNA methylation. Majority of these DMRs are located in the distal promoter regions, suggesting that DMRs are located in the regulatory elements such as enhancers and insulators, important players in epigenetic regulation. Even though distal regulatory elements can be located several kilobases from the core promoter, they can regulate gene expression via loops in the intervening DNA. Functional studies have demonstrated that transcription factor binding can cause demethylation of distal enhancers and activation of gene expression \[[@dvy005-B82]\]. Similar studies need to be conducted to understand the functional relevance of toxicant-induced DMRs. Recently, thousands of DMRs were identified in the developing zebrafish genome and a significant portion were empirically shown to behave as developmental enhancers \[[@dvy005-B27]\]. It is plausible that the DMRs identified in this study might also act as enhancers or insulators and regulate gene expression. Future studies should focus on the functional characterization of DMRs using CRISPR-Cas technology-based epigenome editing. The potential candidates for the functional studies would be those that alter gene expression patterns.

Conclusions
===========

In this study, we demonstrated the effect of a potent AHR agonist (PCB126) on tissue-specific DNA methylation and concomitant gene expression changes in zebrafish. It is known that some toxicants can alter DNA methylation, but to our knowledge there have been no reports on toxicant effects on genome-wide DNA methylation and their relationship with gene expression. Our results suggest that the PCB effects on DNA methylation are distinct from changes in gene expression. Lack of correlation between PCB-induced changes in DNA methylation and gene expression suggests that the relationship between methylation and gene expression is dynamic and complex, involving multiple layers of regulation. As DNA methylation influences gene expression by altering the interaction between DNA, chromatin and transcription factors, understanding the chromatin state will provide insights into the mechanisms of action. Recent methods such as ATAC (Assay for Transposase-Accessible Chromatin using sequencing)-seq and NiCE (Nicking enzyme-assisted sequencing)-seq have enabled genome-wide chromatin profiling. Furthermore, time course studies should be conducted to determine the spatio-temporal dynamics of DNA methylation in response to toxicant exposure. Finally, as zebrafish is extensively used as a toxicological model, it is essential to develop database resources like ENCODE and an epigenomics portal to catalog genome-wide studies for future re-analysis and interpretation.
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